» Articles » PMID: 37402469

Kidney Complications Associated with COVID-19 Infection and Vaccination in Children and Adolescents: a Brief Review

Overview
Specialty Pediatrics
Date 2023 Jul 4
PMID 37402469
Authors
Affiliations
Soon will be listed here.
Abstract

Coronavirus disease 2019 (COVID-19) has spread considerably across the globe, affecting numerous children and adolescents besides adults. Despite its relatively lower incidence rates in children and adolescents than in adults, some infected children and adolescents exhibit a severe postinflammatory response known as multisystem inflammatory syndrome in children, followed by acute kidney injury, a common complication. Meanwhile, few reports have been available regarding kidney complications such as idiopathic nephrotic syndrome and other glomerulopathies associated with COVID-19 infection and vaccination in children and adolescents. However, the morbidity and mortality of these complications are not exceptionally high; more importantly, causality has yet to be clearly established. Finally, vaccine hesitancy in these age groups should be addressed, considering the strong evidence of COVID-19 vaccine safety and efficacy.

Citing Articles

Clinical considerations and practical issues of kidney complications in children after COVID-19 infection or vaccination.

Jung J, Lee J Clin Exp Pediatr. 2023; 67(1):35-36.

PMID: 37986565 PMC: 10764664. DOI: 10.3345/cep.2023.01074.


COVID-19 infection and vaccination among children.

Kleebayoon A, Wiwanitkit V Clin Exp Pediatr. 2023; 66(12):531-532.

PMID: 37654170 PMC: 10694554. DOI: 10.3345/cep.2023.00899.

References
1.
Chiodini B, Bellotti A, Morello W, Bulgaro C, Farella I, Giordano M . Relapse rate in children with nephrotic syndrome during the SARS-CoV-2 pandemic. Pediatr Nephrol. 2022; 38(4):1139-1146. PMC: 9383657. DOI: 10.1007/s00467-022-05702-2. View

2.
Morello W, Vianello F, Bulgaro C, Montini G . Epidemiology, severity, and risk of SARS-CoV-2-related relapse in children and young adults affected by idiopathic nephrotic syndrome: a retrospective observational cohort study. Pediatr Nephrol. 2022; 38(4):1159-1166. PMC: 9510541. DOI: 10.1007/s00467-022-05736-6. View

3.
H Abdel-Qader D, Hazza Alkhatatbeh I, Hayajneh W, Annab H, Al Meslamani A, Elmusa R . IgA nephropathy in a pediatric patient after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine. Vaccine. 2022; 40(18):2528-2530. PMC: 8942577. DOI: 10.1016/j.vaccine.2022.03.003. View

4.
Gonzalez-Dambrauskas S, Vasquez-Hoyos P, Camporesi A, Diaz-Rubio F, Pineres-Olave B, Fernandez-Sarmiento J . Pediatric Critical Care and COVID-19. Pediatrics. 2020; 146(3). DOI: 10.1542/peds.2020-1766. View

5.
Horino T, Sawamura D, Inotani S, Ishihara M, Komori M, Ichii O . Newly diagnosed IgA nephropathy with gross haematuria following COVID-19 vaccination. QJM. 2021; 115(1):28-29. PMC: 8690244. DOI: 10.1093/qjmed/hcab305. View